LOVO-CEL Trademark

Trademark Overview

On Thursday, April 22, 2021, a trademark application was filed for LOVO-CEL with the United States Patent and Trademark Office. The USPTO has given the LOVO-CEL trademark a serial number of 79316992. The federal status of this trademark filing is REGISTERED as of Tuesday, August 30, 2022. This trademark is owned by Bluebird Bio (UK) Ltd.. The LOVO-CEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for treatment of genetic diseases, namely, sickle cell disease
lovo-cel

General Information

Serial Number79316992
Word MarkLOVO-CEL
Filing DateThursday, April 22, 2021
Status700 - REGISTERED
Status DateTuesday, August 30, 2022
Registration Number6829776
Registration DateTuesday, August 30, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for treatment of genetic diseases, namely, sickle cell disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party Namebluebird bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressUS
Party Namebluebird bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressUS
Party Namebluebird bio, Inc.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressUS
Party NameBluebird Bio (UK) Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Tuesday, September 21, 2021ASSIGNED TO EXAMINER
Friday, November 5, 2021REFUSAL PROCESSED BY IB
Thursday, August 5, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 10, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, September 22, 2021NON-FINAL ACTION WRITTEN
Thursday, September 23, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 13, 2021REFUSAL PROCESSED BY MPU
Wednesday, October 13, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 20, 2022CHANGE OF OWNER RECEIVED FROM IB
Tuesday, April 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2022REGISTERED-PRINCIPAL REGISTER
Friday, August 26, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, August 30, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, September 13, 2024NEW REPRESENTATIVE AT IB RECEIVED
Saturday, December 23, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, November 30, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, December 9, 2022FINAL DISPOSITION PROCESSED
Friday, December 9, 2022FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 4, 2023FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

lovo namely sickle cell disease diseases genetic preparations substances treatment pharmaceutical